Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...

Shares of Eli Lilly & Co. LLY shed 1.21% to $923.71 Friday, on what proved to be an all-around positive trading session for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and ...

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas.

Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...

Eli Lilly (LLY) stock gained as Citi resumed its covderage with a buy rating and $1,060 price target, citing optimism for its ...

"Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland" was originally created and published by Pharmaceutical ...

Pharmaceutical giant Eli Lilly (LLY) says it will spend $1.8 billion U.S. to expand its manufacturing capacity as it tries to meet global demand for its recently approved Alzheimer's drug and popular ...

The investments are part of Lilly's ongoing commitment to expand production, especially for its top-selling diabetes and obesity drugs, Mounjaro and Zepbound, respectively. The company has committed ...

Eli Lilly & Co. closed $71.28 below its 52-week high ($972.53), which the company achieved on August 22nd.